RE: atezolizumab approved by this fall as the FDA green-lights?"for patients with locally advanced or metastatic urothelial carcinoma (mUC) who progressed during or after platinum-based chemotherapy in the metastatic setting, or whose disease worsened within 12 months of receiving platinum-based chemotherapy before or after surgery, - See more at: https://global.onclive.com/web-exclusives/fda-grants-atezolizumab-priority-review-in-bladder-cancer#sthash.cbbFdPYD.dpuf"